4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-21-048384
President and CEO acquired 2,666,600 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2021-07-22 | Conversion | +2,666,600 | 2,666,600 | I | ||
| Derivatives | |||||||
| Jiang Wenbin President and CEO | 2021-07-22 | Conversion · Series A Preferred Stock | −2,666,600 | 0 | I | ||
Loading xslF345X03/doc4.xml…